Inventor profile of:

Stephen Robert Wedge

City:

Macclesfield

Country:

Great Britain (UK)

Published Applications:

14

Last publication date:

2012-10-18

Top Assignees for applications by Stephen Robert Wedge

The entities that hold a legal rights for patent applications filed by inventor Wedge Stephen Robert:

Recent patent applications by Wedge Stephen Robert

Stephen Robert Wedge from Macclesfield, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2012-10-18
US20120263802A1
Human necessities

Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability

#2 | 2012-10-04
US20120252826A1
Human necessities

Combination Therapy

#3 | 2011-09-01
US20110212978A1
Human necessities

Combination of ZD6474 and Pemetrexed

#4 | 2011-04-14
US20110086870A1
Human necessities

Combination Therapy

#5 | 2010-08-26
US20100215773A1
Human necessities

Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability

#6 | 2010-07-15
US20100179142A1
Human necessities

Cancer Combination Therapy Comprising AZD2171 and ZD1839

#7 | 2010-05-27
US20100130520A1
Human necessities

COMBINATION THERAPY

#8 | 2010-03-18
US20100069398A1
Human necessities

Combination therapy

#9 | 2009-12-31
US20090325977A1
Human necessities

CANCER COMBINATION THERAPY COMPRISING AZD2171 AND IMATINIB

#10 | 2008-12-11
US20080306094A1
Human necessities

Combination of Azd2171 and Pemetrexed

#11 | 2008-10-30
US20080269261A1
Human necessities

Combination of Zd6474 and Pemetrexed

#12 | 2008-10-02
US20080242663A1
Chemistry; metallurgy

NOVEL PYRIMIDINE DERIVATIVES 698

#13 | 2006-07-27
US20060167027A1
Human necessities

Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability

#14 | 2006-07-27
US20060167024A1
Human necessities

Cancer combination therapy comprising azd2171 and zd1839

InventorID:

3270097 ⎘